4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001586226-26-000002
Interim Executive Chair sold 4,355 shares at $40.00 ($174,214)
- Interim Executive Chair acquired 3,955 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TZIANABOS ARTHUR Interim Executive Chair | 2026-03-10 | Option exercise 10b5-1 | +3,955 | $8.33 | $32,945 | 35,694 | D |
| TZIANABOS ARTHUR Interim Executive Chair | 2026-03-10 | Sale 10b5-1 | −4,355 | $40.00 | $174,214 | 31,339 | D |
| Derivatives | |||||||
| TZIANABOS ARTHUR Interim Executive Chair | 2026-03-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,955 | 118,696 | D | ||
| Open-market sales · 4,355 sh · avg $40.00 · $174,214 | |||||||
Loading xslF345X05/form4-03122026_080323.xml…